South Carolina General Assembly
122nd Session, 2017-2018

Download This Bill in Microsoft Word format

Indicates Matter Stricken
Indicates New Matter

H. 4119

STATUS INFORMATION

General Bill
Sponsors: Reps. G.M. Smith, Spires and Cobb-Hunter
Document Path: l:\council\bills\agm\19166wab17.docx

Introduced in the House on April 6, 2017
Introduced in the Senate on April 25, 2017
Currently residing in the Senate Committee on Medical Affairs

Summary: Renal dialysis facilities

HISTORY OF LEGISLATIVE ACTIONS

     Date      Body   Action Description with journal page number
-------------------------------------------------------------------------------
    4/6/2017  House   Introduced, read first time, placed on calendar without 
                        reference (House Journal-page 55)
    4/6/2017  House   Member(s) request name added as sponsor: Cobb-Hunter
   4/19/2017  House   Read second time (House Journal-page 12)
   4/19/2017  House   Roll call Yeas-107  Nays-0 (House Journal-page 13)
   4/20/2017  House   Read third time and sent to Senate (House Journal-page 7)
   4/25/2017  Senate  Introduced and read first time (Senate Journal-page 10)
   4/25/2017  Senate  Referred to Committee on Medical Affairs 
                        (Senate Journal-page 10)

View the latest legislative information at the website

VERSIONS OF THIS BILL

4/6/2017
4/6/2017-A

(Text matches printed bills. Document has been reformatted to meet World Wide Web specifications.)

INTRODUCED

April 6, 2017

H. 4119

Introduced by Reps. G.M. Smith and Spires

S. Printed 4/6/17--H.

Read the first time April 6, 2017.

            

A BILL

TO AMEND THE CODE OF LAWS OF SOUTH CAROLINA, 1976, BY ADDING SECTION 40-43-75 SO AS TO PROVIDE RENAL DIALYSIS FACILITIES MAY DELIVER LEGEND DRUGS OR DEVICES TO PATIENTS IN CERTAIN CIRCUMSTANCES, TO DEFINE NECESSARY TERMS, AND TO PROVIDE THESE PROVISIONS DO NOT WAIVE OTHER NECESSARY CREDENTIALING REQUIREMENTS FOR INDIVIDUALS AND FACILITIES.

Be it enacted by the General Assembly of the State of South Carolina:

SECTION    1.    Chapter 43, Title 40 of the 1976 Code is amended by adding:

"Section 40-43-75.    (A)    For purposes of this section:

(1)    'Renal Dialysis Facility' or 'RDF' means an outpatient facility that treats and offers staff-assisted dialysis or training and support services for self-dialysis patients to end-stage renal disease patients, as defined by Centers for Medicare and Medicaid Services. An RDF may be composed of one or more fixed buildings, mobile units, or a combination of them, as defined in R. 61-91.101(Q). An RDF must be certified by Medicare to provide dialysis-related services to ESRD patients and must have a medical director licensed as a physician, pursuant to Chapter 47, of this title on staff.

(2)    'End Stage Renal Disease' or 'ESRD' means the disease state, and associated conditions, defined under 42 C.F.R. 406.13 and the United States Social Security Act.

(B)    An RDF may deliver a legend drug or device to a patient of an RDF if:

(1)    the drug or device is for home use by the patient or administration in the facility as required by the prescriber's order or prescription;

(2)    the drug or device is dispensed to the RDF by a properly licensed resident or nonresident pharmacy licensed by the board or administered by a properly licensed healthcare practitioner;

(3)    the drug or device is dispensed by the pharmacy pursuant to a valid prescription issued by a licensed practitioner, as defined in Section 40-43-30(45);

(4)    the drug or device delivered by the RDF is properly labeled in accordance with state and federal law;

(5)    the drug or device is held by the RDF in a secure location in an area not accessible to the public, and packages containing drugs or devices are delivered by RDF staff, unopened, to the patient;

(6)    the patient is given a choice of receiving the drug or device from the RDF, at their home, or from another agent;

(7)    the drugs exclude controlled substances; and

(8)    the RDF maintains policies and procedures concerning how it will receive, store, maintain, and return any drugs or devices that are not picked up by the patient and returned to the dispensing pharmacy.

(C)    The provisions of this section do not waive any other requirements to obtain licensure, permit, or certification as required by law to possess legend drug products. A facility engaged in an activity related to the delivery or distribution of legend drugs still shall hold the requisite licensure or drug permits required by law."

SECTION    2.    This act takes effect upon approval by the Governor.

----XX----

This web page was last updated on April 26, 2017 at 9:03 AM